To include your compound in the COVID-19 Resource Center, submit it here.

Analyst picks & changes

Analyst picks & changes

Company Bank Analyst Coverage Opinion Wk chg 6/3 close
AMAG Pharmaceuticals Inc. (NASDAQ:AMAG) Baird Christopher Raymond Upgrade Market outperform (from neutral) 7% $17.92
Raymond also raised his target to $22 from $19, saying he thinks AMAG shares have "bottomed" and expects the

Read the full 605 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers